LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
31.38
-0.43 (-1.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $899.84 million as of April 29, 2026.
Market Cap
899.84M
Enterprise Value
608.20M
1-Year Change
n/a
Ranking
Category
Stock Price
$31.38
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $899.84M, an increase of 198.45%. That is a compound annual growth rate of 471.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 899.84M | 59.78% |
| Dec 31, 2025 | 563.16M | 86.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 921.35M |
| Sana Biotechnology | 919.15M |
| Maravai LifeSciences Holdings | 913.87M |
| Phathom Pharmaceuticals | 899.94M |
| CytomX Therapeutics | 896.90M |
| Xencor | 891.06M |
| Janux Therapeutics | 882.06M |
| SELLAS Life Sciences Group | 876.36M |